On February 12, 2026 CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, reported that senior management will be presenting and participating in investor meetings at upcoming investor conferences taking place in March.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Leerink Partners Global Healthcare Conference
Date: March 10, 2026
Time: 1:00pm Eastern
Format: Fireside Chat
Webcast: Link to webcast

Citizens Life Sciences Conference
Date: March 11, 2026
Time: 9:35am Eastern
Format: Fireside Chat
Webcast: Link to webcast

Barclays 28th Annual Global Healthcare Conference
Date: March 12, 2026
Format: One-on-one investor meetings

(Press release, CorMedix, FEB 12, 2026, View Source [SID1234662636])